Ubrogepant Safety, Efficacy Not Affected by Triptans Ubrogepant Safety, Efficacy Not Affected by Triptans

The CGRP receptor antagonist shows promise, but hurdles set up by insurance companies limit its potential, experts say.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news